Recent Articles from GlobeNewswire

Thousands of AI-generated “personalities” around the world to compete for the AI Personality of the Year Awards 2026 - as expert estimates there’s now more AI personas online than the population of New York
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- OpenArt, the leading AI video generation platform, has partnered with creator subscription platform, Fanvue, to launch the AI Personality of the Year Awards. The global programme is the first of its kind to recognise the achievements of AI Influencers across content excellence, cultural impact, and commercial success, with ElevenLabs joining in as a founding partner. 
By Fanvue · Via GlobeNewswire · April 3, 2026
MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell therapies to restore immune balance and treat immune-mediated diseases and cancer, today announced that data from an investigator-initiated Phase II trial at Memorial Sloan Kettering Cancer Center, evaluating agent-797, MiNK’s allo-iNKT cell therapy, in combination with botensilimab (BOT) and balstilimab (BAL), will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 17-22, 2026, in San Diego, CA.
By MiNK Therapeutics · Via GlobeNewswire · April 3, 2026
Figure Technology Solutions Reports Preliminary March & Q1 2026 Operating Data
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Figure Technology Solutions (Nasdaq: FIGR; OPEN: FGRS), the leading blockchain-native capital marketplace for the origination, funding, sale, and trading of tokenized assets, today reported select preliminary operating data for the month and quarter ended March 31, 2026.
Halper Sadeh LLC is Investigating Whether UNF, CYCN, NSA, ULYX are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 
By Halper Sadeh LLC · Via GlobeNewswire · April 3, 2026
Plug Power CEO Jose Luis Crespo to Host Reddit AMA on April 16
Live Q&A to Address Company Strategy, Market Position, and the Future of Hydrogen
By Plug Power, Inc. · Via GlobeNewswire · April 3, 2026
Wix Announces Final Results of Modified Dutch Auction Tender Offer
NEW YORK—Wix.com Ltd. (Nasdaq: WIX) (“Wix” or the “Company”) today announced the final results of its “modified Dutch Auction” tender offer, which expired at one (1) minute after 11:59 P.M., New York City time, on April 1, 2026. 
By Wix.com, Ltd. · Via GlobeNewswire · April 3, 2026
Daofu Apricot Blossom Festival Highlights New Cultural-Tourism Integration on the Plateau
GANZI, China, April 03, 2026 (GLOBE NEWSWIRE) -- On April 2, the 2026 Conference on Cultural-Tourism Integration & the First Apricot Blossom Eco-Culture Week opened in Daofu County, Ganzi Tibetan Autonomous Prefecture, Sichuan, China. The event was hosted by the CPC Daofu County Committee and the Daofu County People's Government. With blooming apricot blossoms as its centerpiece, the event unveiled a series of tourism incentive policies and unique experiences, showcasing Daofu's innovative practices to integrate ecotourism with cultural heritage preservation.
MEXC Announces USD1 Launchpool Event with 1,500,000 WLFI Prize Pool
By MEXC · Via GlobeNewswire · April 3, 2026
Crossing the Privacy Divide: Dmitry Shubov Speaks on How Southeast Asian Legal-Tech Founders Can Confidently Enter the U.S. Market
FREMONT, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- Launching a Southeast Asian legal-tech startup in the U.S. is an exciting milestone, but it comes with a major hurdle: American buyers and investors are putting a magnifying glass on how you handle data. Founders who treat cross-border privacy as a core feature, rather than a last-minute chore, could be closing deals faster and winning over users much more easily. Research from the Future of Privacy Forum (FPF) underscores the growing complexity of navigating ASEAN privacy rules alongside fragmented U.S. state laws—a regulatory challenge that increasingly influences U.S. purchasing and investment decisions.
By Dmitry Shubov Consulting · Via GlobeNewswire · April 3, 2026
MEXC Integrates USD1 into Full-Spectrum Infrastructure for Global Users
By MEXC · Via GlobeNewswire · April 3, 2026
STMicroelectronics Announces Timing for First Quarter 2026 Earnings Release and Conference Call
STMicroelectronics Announces Timing for First Quarter 2026 Earnings Release and Conference Call
ArcelorMittal has published a convening notice for its Annual General Meeting and Extraordinary General Meeting of shareholders to be held on 5 May 2026
3 April 2026, 8.00am CET
By ArcelorMittal S.A. · Via GlobeNewswire · April 3, 2026
OwlTing Group (NASDAQ: OWLS) Receives US$10 Million Investment with up to US$50 Million in Total Funding Available Upon Mutual Consent
ARLINGTON, Va., April 03, 2026 (GLOBE NEWSWIRE) -- OwlTing Group (NASDAQ: OWLS) (“OwlTing” or the “Company”), the operating brand of OBOOK Holdings Inc., a global fintech company, today announced that it has entered into a Securities Purchase Agreement (the “SPA”) with Lind Global Asset Management XV LLC (the “Investor”), an investment fund managed by The Lind Partners, a New York-based institutional fund manager, for the issuance and sale of a convertible security (the “Convertible Security”) for US$10 million in gross proceeds. The arrangement will provide the Company with access to up to US$50 million in total funding, consisting of the initial US$10 million investment at closing of the Convertible Security (the “Closing”) and up to US$40 million in additional follow-on investments after effective resale registration, subject to similar terms and mutual consent of both parties. The Closing is expected to occur on or around April 6, 2026, subject to satisfaction of customary closing conditions. Benchmark, a StoneX Company, acted as exclusive placement agent.
By OwlTing Group · Via GlobeNewswire · April 3, 2026
Get Lost Pest Control Announces Free First Appointment and Two-Day Response Commitment for New Service Plan Customers
Meridian, Idaho, April 02, 2026 (GLOBE NEWSWIRE) -- Get Lost Pest Control, a pest management provider serving Boise and the greater Treasure Valley, today announced a procedural update for new residential Service Plan customers. Under the new policy, the company will provide the first appointment at no cost while guaranteeing scheduling within two days. The announcement formalizes an operational shift intended to simplify onboarding for households seeking pest control services in the region.
By Get Lost Pest Control · Via GlobeNewswire · April 2, 2026
Inc. Names Next Point LLC to Its 2026 List of the Fastest-Growing Private Companies in the Northeast
Recognition Underscores the Firm’s Expansion as a Western New York–Based M&A Advisor Serving Clients Nationwide in Manufacturing, Industrial, and Healthcare
By Next Point LLC · Via GlobeNewswire · April 2, 2026
IBRX SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of ImmunityBio, Inc. Investors - Contact Kirby McInerney LLP by May 26, 2026
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ:IBRX) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via GlobeNewswire · April 2, 2026
KD DEADLINE NOTICE: Kyndryl Holdings, Inc. Investors Encouraged to Contact Kirby McInerney LLP By April 13, 2026
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- If you suffered a loss on your investment in Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE:KD), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via GlobeNewswire · April 2, 2026
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Vital Farms, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - VITL
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 2, 2026
Nobody Could Answer the CFO’s Question on the ROI from AI Adoption; TechWish Built a Platform That Can
Platform validated at a major Fortune 500 energy company, establishing an estimated 20× productivity ROI and 44% increase in active Copilot utilization within 90 days
By TechWish LLC · Via GlobeNewswire · April 2, 2026
GO INVESTOR REMINDER: Grocery Outlet Holdings Corp. Investors Have Until May 15, 2026 To Seek Lead Plaintiff Role
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- If you have suffered a loss on your Gocery Outlet Holdings Corp. (“Grocery Outlet” or the “Company”) (NASDAQ:GO) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via GlobeNewswire · April 2, 2026
SMCI SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Super Micro Computer, Inc. Investors - Contact Kirby McInerney LLP by May 25, 2026
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NASDAQ:SMCI) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via GlobeNewswire · April 2, 2026
UNIQURE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important April 13 Deadline in Securities Class Action - QURE
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 2, 2026
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kyndryl Holdings and Masonite International and Encourages Investors to Contact the Firm
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Kyndryl Holdings, Inc. (NYSE:KD) and Masonite International Corporation (NYSE:DOOR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · April 2, 2026
ODDITY INVESTOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ODDITY Tech Ltd. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Oddity (ODD) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · April 2, 2026
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., April 02, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 15, 2026, to shareholders of record at the close of business on May 29, 2026.
By Mesa Laboratories, Inc. · Via GlobeNewswire · April 2, 2026
MONDAY.COM LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Encourages Monday.com Investors to Contact the Firm Before the May 11th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In monday.com (MNDY) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · April 2, 2026
Bragar Eagel & Squire, P.C. Urges Trip.com Limited Stockholders with Large Losses to Contact the Firm Regarding Their Rights
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Trip.com (TCOM) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · April 2, 2026
UNIQURE DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm Before April 13th
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In uniQure (QURE) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · April 2, 2026
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NAARDEN, the Netherlands and MIAMI, April 02, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam’s Board of Directors approved the grant of inducement share options covering an aggregate of 15,000 of NewAmsterdam’s ordinary shares to two non-executive new hires. The share options were granted as an inducement material to the employees acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).
By NewAmsterdam Pharma N.V. · Via GlobeNewswire · April 2, 2026
DeFi Development Corp. to Host X Spaces Event: “DFDV March 2026 Recap & AMA + FY 2025 Earnings Breakdown”
BOCA RATON, FL, April 02, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (“DFDV” or the “Company”), the first U.S. public company with a treasury strategy built around accumulating and compounding Solana (SOL), today announced it will host a live X Spaces event on Monday, April 6, 2026, at 1:00 PM ET.
By DeFi Development Corporation · Via GlobeNewswire · April 2, 2026
Mattr Announces Closing of Credit Facility Extension
TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced that it has successfully closed on an amendment to its credit facility with The Toronto-Dominion Bank and National Bank of Canada as co-lead arrangers and Royal Bank of Canada, JP Morgan Chase Bank, Export Development Canada and ATB Financial as lenders to extend the US$300 million senior secured revolving facility until October 2030.
By Mattr Corp. · Via GlobeNewswire · April 2, 2026
NEW ERA ENERGY LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against New Era Energy & Digital, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In New Era Energy (NUAI) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · April 2, 2026
2026 Annual General Meeting
Further to the press release of March 26, 2026 giving notice that the Golar LNG Limited 2026 Annual General Meeting will be held on May 19, 2026, a copy of the Notice of Annual General Meeting and associated information including the Company’s Annual Report on Form 20-F can be found on our website at https://www.golarlng.com and in the attachments below.
By Golar LNG · Via GlobeNewswire · April 2, 2026
Barrick Provides an Update on Reko Diq
All amounts expressed in U.S. dollars
By Barrick Mining Corporation · Via GlobeNewswire · April 2, 2026
Pick Your Perfect Cultural Escape During MOSAIC
Month of Shows, Art, Ideas and Culture Returns to The Palm Beaches this May with Record Number of Deals and Special Experiences for All Ages
Centerra Gold Provides Notice of First Quarter 2026 Results and Conference Call and Details for Annual Meeting of Shareholders
TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) will release its first quarter 2026 operating and financial results after the market closes on Wednesday April 29, 2026. The Company will host a conference call and webcast to discuss the results on Thursday April 30, 2026 at 9:00 a.m. Eastern Time. Details for the conference call and webcast are included below.
By Centerra Gold Inc · Via GlobeNewswire · April 2, 2026
Real Music. Real Artists. Mini Size
Introducing MGA’s Miniverse Real Music™: Big Hits Come to Life in Miniature with a Playable Mini Record Player and Collectible Mini Vinyls
By MGA Entertainment · Via GlobeNewswire · April 2, 2026
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Super Micro Computer, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SMCI
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 2, 2026
Weatherford Announces Proposal to Redomesticate to the United States, Establishing Texas as New Legal Domicile
Move reflects continued execution of Weatherford’s free-cash-flow-focused strategy to streamline corporate structure, enhance capital management flexibility and deliver long-term shareholder value
ROSEN, THE FIRST FILING FIRM, Encourages Trip.com Group Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TCOM
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 2, 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026
By DBV Technologies S.A. · Via GlobeNewswire · April 2, 2026
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, April 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to four new employees to purchase an aggregate of 188,500 shares of the Company's common stock, effective as of April 1, 2026. These awards were approved by the Compensation Committee of Olema’s Board of Directors and granted under the Company's 2022 Inducement Plan as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
By Olema Oncology · Via GlobeNewswire · April 2, 2026
OceanFirst Financial Corp. Schedules Earnings Conference Call
RED BANK, N.J., April 02, 2026 (GLOBE NEWSWIRE) -- OceanFirst Financial Corp. (NASDAQ:OCFC), the holding company for OceanFirst Bank, today announced that it will issue its earnings release for the quarter ended March 31, 2026, on Thursday, April 23, 2026, after the market close. Management will then conduct a conference call at 11:00 a.m. Eastern Time, on Friday, April 24, 2026, to discuss highlights of the Company's quarterly operating performance.
By OceanFirst Financial Corp. · Via GlobeNewswire · April 2, 2026
Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX’s industry-leading global network of electronic health record data
KBR’s Mission Technology Solutions Supports NASA’s Artemis II Mission as Astronauts Embark on Historic Return to the Moon
HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- KBR‘s (NYSE: KBR) Mission Technology Solutions business is delivering critical services to support astronauts on NASA’s Artemis II mission as they embark on their journey around the moon – the first human mission beyond low-Earth orbit since Apollo 17 in 1972. From inside Mission Control, KBR teams are providing real-time monitoring and control of spacecraft systems and astronaut health, helping to ensure crew safety and the success of this landmark endeavor.
By Kellogg Brown & Root LLC. · Via GlobeNewswire · April 2, 2026
Exodus to Host Inaugural Shareholder Day, The Exodus Summit on May 1 in Omaha
The company will showcase its self-custodial payments platform the day before Berkshire Hathaway’s annual shareholder meeting.
By Exodus · Via GlobeNewswire · April 2, 2026
Mohawk Industries, Inc. Invites You to Join its First Quarter Earnings Conference Call
CALHOUN, Ga., April 02, 2026 (GLOBE NEWSWIRE) -- In conjunction with Mohawk Industries’ (NYSE: MHK) First Quarter 2026 earnings release on Thursday, April 30, 2026, you are invited to listen to the conference call that will be broadcast live on Friday, May 1, 2026, at 11:00 am ET.
By Mohawk Industries, Inc. · Via GlobeNewswire · April 2, 2026
American Assets Trust, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Information
SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its first quarter 2026 earnings in a press release to be issued after the market closes on Tuesday, April 28, 2026.
By American Assets Trust, Inc. · Via GlobeNewswire · April 2, 2026
Riot Announces First Quarter 2026 Production and Operations Updates
CASTLE ROCK, Colo., April 02, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), a Bitcoin-driven industry leader in the development of large-scale data centers and bitcoin mining applications, announces unaudited production and operations updates for the first quarter of 2026.   Bitcoin Production and Operations Updates for Q1 2026
By Riot Platforms, Inc. · Via GlobeNewswire · April 2, 2026
ULTRAGENYX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – RARE
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 2, 2026
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
ALISO VIEJO, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Management is scheduled to participate in a fireside chat on Thursday, April 16, 2026, at 8:00 a.m. Pacific Time. A live and archived webcast of the presentation will be available on the company’s investor relations website at https://investors.rxsight.com/.
By RxSight, Inc. · Via GlobeNewswire · April 2, 2026
ACM Research Introduces ACM Planetary Family™ Product Portfolio Structure
New portfolio structure reinforces ACM’s customer‑centric approach across core process technologies
By ACM Research, Inc. · Via GlobeNewswire · April 2, 2026
Grocery Outlet Holding Corp. Adds Two New Independent Directors
Frances Allen and Felicia Thornton Bring Seasoned Retail Leadership and Operating Expertise to Board
By Grocery Outlet, Inc. · Via GlobeNewswire · April 2, 2026
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on April 1, 2026, the Company granted restricted stock units (RSUs) representing 7,260 shares of its common stock to one newly-hired non-executive employee. The grant was approved by the Compensation Committee of the Company’s Board of Directors and granted under the Company’s Amended and Restated Inducement Equity Plan as an inducement material to the new employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employee being continuously employed by the Company through each vesting date.
By Fate Therapeutics, Inc. · Via GlobeNewswire · April 2, 2026
Encore Capital Group to Announce First Quarter 2026 Financial Results on May 6
SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- Encore Capital Group, Inc. (Nasdaq:ECPG), an international specialty finance company, announced today that it will release its financial results for the first quarter 2026 on Wednesday, May 6, 2026, after the market closes. The Company will also host a conference call and slide presentation the same day at 2:00 p.m. Pacific / 5:00 p.m. Eastern time with Ashish Masih, President and Chief Executive Officer, Tomas Hernanz, Executive Vice President and Chief Financial Officer, and Bruce Thomas, Vice President, Global Investor Relations, presenting and discussing the reported results.
By Encore Capital Group, Inc. · Via GlobeNewswire · April 2, 2026
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
CAMBRIDGE, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that initial clinical results and preclinical data for zovegalisib (RLY-2608) in vascular anomalies will be presented at the International Society for the Study of Vascular Anomalies (ISSVA) World Congress 2026, taking place May 19-22, 2026, in Philadelphia. The company anticipates reporting clinical data on approximately 20 efficacy-evaluable patients.
By Relay Therapeutics, Inc. · Via GlobeNewswire · April 2, 2026
Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics
NEW YORK and ANN ARBOR, Mich., April 02, 2026 (GLOBE NEWSWIRE) -- Athyrium Capital Management, LP and Esperion Therapeutics, Inc. (Nasdaq: ESPR) today announced the entry into a $50 million royalty financing agreement under which certain funds managed by Athyrium Capital Management (the “Athyrium Funds”) will acquire 100% of Esperion’s royalty interest, held by Esperion pursuant to that certain License and Collaboration Agreement, dated as of April 17, 2020, as amended, by and among Esperion and Otsuka Pharmaceutical Co., Ltd (“Otsuka”), of Otsuka’s net sales of bempedoic acid products in Japan from and after January 1, 2026, together with related regulatory and commercial milestone payments, subject to a cap.
Minerva Announces Leadership Transition
Jim O’Connor joins as Chief Business Officer and General Counsel
By Minerva Neurosciences, Inc · Via GlobeNewswire · April 2, 2026
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that it has granted as of April 1, 2026 equity inducement awards to three new employees under the terms of the 2022 Employment Inducement Award Plan, as amended. The equity awards were approved by the Compensation Committee of the Company’s Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4) and were made as a material inducement to the employees’ acceptance of employment with Terns.
By Terns Pharmaceuticals, Inc. · Via GlobeNewswire · April 2, 2026
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEEDHAM, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that on March 31, 2026, the Compensation Committee of Candel’s Board of Directors (the Board) granted to five new employees, stock options to purchase an aggregate of 70,000 shares of the Company’s common stock, with a per share exercise price of $4.90.
By Candel Therapeutics · Via GlobeNewswire · April 2, 2026
PMGC Holdings Inc. Announces the Formation of New Subsidiary, NorthStrive Defense Tech to Target High-Growth Defense, Drone and Autonomous Systems Sector
NEWPORT BEACH, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (the “Company” or “PMGC”) (NASDAQ: ELAB), a diversified holding company, today announced the launch of a new wholly owned subsidiary, NorthStrive Defense Tech LLC (“NorthStrive Defense Tech”). The Company plans for NorthStrive Defense Tech to operate in the defense technology sector, with an emphasis on drone technology, autonomous systems, and next generation unmanned defense solutions.
By PMGC Holdings Inc. · Via GlobeNewswire · April 2, 2026
Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026
AUSTIN, Texas, April 02, 2026 (GLOBE NEWSWIRE) -- Ethos Technologies Inc. (NASDAQ: LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced that it will release its financial results for the first quarter of 2026, which ended March 31, 2026, following the close of U.S. financial markets on Wednesday, May 6, 2026. The company’s earnings press release will be made available on the Ethos Investor Relations website at investors.ethos.com.
By Ethos Technologies Inc · Via GlobeNewswire · April 2, 2026
Astera Labs Announces Conference Call to Review First Quarter 2026 Financial Results
SANTA CLARA, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced that it will release its financial results for the first quarter 2026 after the close of market on Tuesday, May 5, 2026. Astera Labs will host a corresponding conference call at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time.
By ASTERA LABS, INC. · Via GlobeNewswire · April 2, 2026
HMH Holding Inc. Announces Closing of Initial Public Offering
HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- HMH Holding Inc. (“HMH”) (NASDAQ: HMH) today announced the closing of its initial public offering of 10,520,000 shares of its Class A common stock at $20.00 per share. The underwriters have a 30-day option to purchase up to an additional 1,578,000 shares of Class A common stock from HMH at the initial public offering price, less underwriting discounts and commissions. The shares of Class A common stock began trading on The Nasdaq Global Select Market on April 1, 2026 under the ticker symbol “HMH.” HMH received net proceeds from the offering of approximately $193.8 million, after deducting underwriting discounts and commissions and estimated offering expenses, and excluding any exercise of the underwriters’ option to purchase additional shares.
By HMH Holding Inc. · Via GlobeNewswire · April 2, 2026
Credit Acceptance Celebrates Being Named No. 18 on Fortune's 2026 100 Best Companies to Work For® List
Southfield, Michigan, April 02, 2026 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) has been named one of the Fortune 100 Best Companies to Work For® in 2026 by Great Place To Work® and Fortune for the 12th time. This year, Credit Acceptance moved up 16 spots to #18, our highest ranking ever.
By Credit Acceptance Corporation · Via GlobeNewswire · April 2, 2026
FibroBiologics Announces Closing of $3 Million Public Offering
HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the closing of its previously announced best efforts public offering of an aggregate of 2,272,728 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 2,272,728 shares of common stock (the “Warrants”), at a combined public offering price of $1.32 per share (or per common stock equivalent in lieu thereof) and accompanying Warrant. The Warrants have an exercise price of $1.32 per share and are exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Warrants (the “Stockholder Approval”) and will expire on the five-year anniversary of the date of Stockholder Approval.
By FibroBiologics, Inc. · Via GlobeNewswire · April 2, 2026
Media Advisory-Axonius Adapt 2026: Closing the Cybersecurity Actionability Gap with Asset Intelligence in the AI Age
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Axonius, the asset intelligence platform for unified security operations and exposure management, today announced the full speaker and session lineup for Axonius Adapt 2026, its annual cybersecurity industry and customer conference taking place in person on April 15, 2026, at Cipriani Wall Street in New York City.
By Axonius Inc. · Via GlobeNewswire · April 2, 2026
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, April 02, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that on April 1, 2026, the Compensation Committee of Praxis’ Board of Directors granted restricted stock unit awards covering an aggregate of 3,558 shares of its common stock to eighteen new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit awards were granted as inducements material to the employees’ entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).
Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
– Enbumyst, First and Only FDA-Approved Nasal Spray Loop Diuretic Now Integrated into Esperion’s Cardiovascular Franchise, Anticipated to Drive Portfolio Expansion, Commercial Leverage, and Continued Revenue Growth –
By Esperion Therapeutics, Inc. · Via GlobeNewswire · April 2, 2026
CN Reports March Grain Movement
MONTREAL, April 02, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that it moved more than 2.96 million metric tonnes of grain from Western Canada, setting a new record for the month of March and achieved our highest ever first quarter results for grain movement. Weekly volumes exceeded 600,000 tonnes for two consecutive weeks, reaching a peak of over 650,000 tonnes, reflecting robust network performance and demand across both the West Coast and eastern corridors.
Advanced Serial Plasma Exchange Now Available in Miami as Environmental Toxin Concerns Rise Across South Florida
MDLifespan launches inside Cenegenics Miami and announces educational event with MDLifespan’s Dr. Pamela W. Smith on the latest break through in longevity and health optimization
By MDLifespan · Via GlobeNewswire · April 2, 2026
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
By MediWound Ltd. · Via GlobeNewswire · April 2, 2026
IGEL Now & Next® 2026 Concludes in Miami with Breakthroughs in Secure Endpoints, Modern EUC, and Ecosystem Innovation
Event highlights innovations and ecosystem integrations across IGEL's platform, spanning endpoint security, digital workspace delivery, and strategic partner expansion
By IGEL · Via GlobeNewswire · April 2, 2026
TextUs Releases AI-Powered SMS with Smart Delivery, Combining AI Messaging, Risk Detection, and Compliance Controls
New features help businesses detect risky messages, reduce opt-outs, and ensure more texts reach their intended audience.
By www.textus.com · Via GlobeNewswire · April 2, 2026
The Thurgood Marshall College Fund and Association of College and University Educators expand partnership
Washington, D.C., April 02, 2026 (GLOBE NEWSWIRE) -- The Thurgood Marshall College Fund (TMCF) and the Association of College and University Educators (ACUE) are expanding their partnership through the Community for HBCU Advancement Through Networked Growth and Excellence (CHANGE) Initiative.